Fuso Pharmaceutical Industries,Ltd. (4538.T) JPX

Currency In JPY

AD

Valuation

Market Cap20.18B
Enterprise Value43.79B
P/E Ratio8.72
PEG Ratio0.09
Price/Sales Ratio0.28
Price/Book Ratio0.5
Enterprise/Revenue0.66
Enterprise/EBITDA7.64

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.03
Operating Margin0.04
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.06

Income Statement

Revenue62.31B
Revenue/Share7,299.32
Gross Profit16B
EBITDA5.38B
Net Income2.01B
Diluted EPS235.52

Balance Sheet

Total Cash4.85B
Total Cash/Share567.71
Total Debt28.46B
Total Debt/Equity0.81
Current Ratio1.11
Book Value Per Share4,107.31

Price History

52-Week Change-1.53
52-Week High2,530
52-Week Low1,990
Moving Average 50 Days2,130.78
Moving Average 200 Days2,238.33

Statistics

Average Volume28,747
Shares Outstanding8.54M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate90
Trailing Annual Dividend Yield4.38
Payout Ratio0
Last Split Factor1:10
Last Split DateSeptember 28, 2016
AD